by Waylon Wright | Jan 12, 2018
Venture capital funding within the life sciences industry has been on a tear in recent years. VC investments broke records in 2015, receded slightly in 2016, and surged back in 2017 to break more records, particularly in the biotech and genetics sectors. Funding for...
by Waylon Wright | Jan 5, 2018
Regulatory professionals have complicated jobs with many types of demands; tight timelines, divisional overlap and complex project plans. It’s therefore critical that regulatory professionals be persuasive, engaging and influential within their companies and health...
by Waylon Wright | Dec 28, 2017
The U.S. Food and Drug Administration (FDA) released a new draft guidance on December 15, 2017 detailing updates to its least burdensome approach to regulation medical devices. The draft follows FDA’s signal that it would move more of the regulatory oversight of...
by Waylon Wright | Dec 22, 2017
Pearl Pathways is proud to announce that Pearl IRB, our full-service central independent review board, has been granted full reaccreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The Final Site Visit Report was...
by Waylon Wright | Dec 18, 2017
Gretchen Bowker, Co-Founder and COO of Pearl Pathways, will share insights during an Indiana Health Industry Forum (IHIF) lunch event on Tuesday, December 19, 2017. The lunch event, “Perspectives on the FDA” is part of IHIF’s recurring Life Sciences...
